These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 24007836)

  • 1. Letter to the editor regarding manuscript entitled: completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L. Eur J Surg Oncol. 2013 Jun;39(6):601-7.
    Kirwan CC; Debnath D; Howe MC; Johnson RK; Bundred NJ
    Eur J Surg Oncol; 2013 Nov; 39(11):1294-5. PubMed ID: 24007836
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the editor regarding response to manuscript entitled: completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution. Grabau D, Dihge L, Ferno M, Ingvar C, Ryden L. Eur J Surg Oncol. 2013 Jun;39(6):601-7.
    Grabau D
    Eur J Surg Oncol; 2013 Nov; 39(11):1296-7. PubMed ID: 23993459
    [No Abstract]   [Full Text] [Related]  

  • 3. Completion axillary dissection can safely be omitted in screen detected breast cancer patients with micrometastases. A decade's experience from a single institution.
    Grabau D; Dihge L; Fernö M; Ingvar C; Rydén L
    Eur J Surg Oncol; 2013 Jun; 39(6):601-7. PubMed ID: 23579175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary lymph node dissection for sentinel lymph node micrometastases may be safely omitted in early-stage breast cancer patients: long-term outcomes of a prospective study.
    Langer I; Guller U; Viehl CT; Moch H; Wight E; Harder F; Oertli D; Zuber M
    Ann Surg Oncol; 2009 Dec; 16(12):3366-74. PubMed ID: 19760047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Micrometastatic sentinel lymph node disease: do patients benefit or suffer harm from axillary lymph node dissection?
    Ziogas D; Zografos GC
    Ann Surg Oncol; 2010 Mar; 17(3):936-7; author reply 938. PubMed ID: 19937389
    [No Abstract]   [Full Text] [Related]  

  • 6. Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital.
    Ogiya A; Kimura K; Nakashima E; Sakai T; Miyagi Y; Iijima K; Morizono H; Makita M; Horii R; Akiyama F; Iwase T
    Breast Cancer; 2016 Mar; 23(2):318-22. PubMed ID: 25376341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer.
    Pargaonkar AS; Beissner RS; Snyder S; Speights VO
    Arch Pathol Lab Med; 2003 Jun; 127(6):701-5. PubMed ID: 12741893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of sentinel lymph node biopsy in detection of axillary lymph node metastasis in breast cancer].
    Zhang JG; Zhong L; Li CL
    Zhonghua Zhong Liu Za Zhi; 2007 Mar; 29(3):235-6. PubMed ID: 17649646
    [No Abstract]   [Full Text] [Related]  

  • 9. Factors predicting non-sentinel lymph node involvement in sentinel node positive breast carcinoma.
    Durak MG; Akansu B; Akin MM; Sevınç AI; Koçdor MA; Saydam S; Harmancioğlu O; Ellıdokuz H; Bekış R; Canda T
    Turk Patoloji Derg; 2011; 27(3):189-95. PubMed ID: 21935867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary node staging for microinvasive breast cancer: is it justified?
    Lyons JM; Stempel M; Van Zee KJ; Cody HS
    Ann Surg Oncol; 2012 Oct; 19(11):3416-21. PubMed ID: 22576061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chylous leakage after axillary lymph node dissection in a patient with breast cancer.
    Oba T; Ono M; Iesato A; Hanamura T; Watanabe T; Ito T; Kanai T; Maeno K; Ito KI
    Breast J; 2018 May; 24(3):438-440. PubMed ID: 29063644
    [No Abstract]   [Full Text] [Related]  

  • 12. The prognostic value of sentinel lymph node micrometastases in patients with invasive breast carcinoma.
    Cipolla C; Graceffa G; La Mendola R; Fricano S; Fricano M; Vieni S
    Ann Ital Chir; 2015; 86():497-502. PubMed ID: 26898168
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axillary reverse mapping in patients with breast cancer: Is it oncologically safe?
    Ngui NK; French J; Kilby CJ; Pathmanathan N; Elder EE
    J Surg Oncol; 2016 Jun; 113(7):726-31. PubMed ID: 27041002
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discordance of intraoperative frozen section analysis with definitive histology of sentinel lymph nodes in breast cancer surgery: complementary axillary lymph node dissection is irrelevant for subsequent systemic therapy.
    Geertsema D; Gobardhan PD; Madsen EV; Albregts M; van Gorp J; de Hooge P; van Dalen T
    Ann Surg Oncol; 2010 Oct; 17(10):2690-5. PubMed ID: 20422461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A differential intra-operative molecular biological test for the detection of sentinel lymph node metastases in breast carcinoma. An extended experience from the first U.K. centre routinely offering the service in clinical practice.
    Babar M; Madani R; Thwaites L; Jackson PA; Devalia HL; Chakravorty A; Irvine TE; Layer GT; Kissin MW
    Eur J Surg Oncol; 2014 Mar; 40(3):282-8. PubMed ID: 24331309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Axillary lymph node dissection is not obligatory in breast cancer patients with biopsy-proven axillary lymph node metastasis.
    Yoo TK; Kang BJ; Kim SH; Song BJ; Ahn J; Park WC; Chae BJ
    Breast Cancer Res Treat; 2020 Jun; 181(2):403-409. PubMed ID: 32328848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Another variable in lymph node biopsy.
    Rogers LW; Ries SG
    Am J Clin Pathol; 2000 Aug; 114(2):293-5. PubMed ID: 10941348
    [No Abstract]   [Full Text] [Related]  

  • 18. A logistic regression model predicting high axillary tumour burden in early breast cancer patients.
    Barco I; García Font M; García-Fernández A; Giménez N; Fraile M; Lain JM; Vallejo E; González S; Canales L; Deu J; Vidal MC; Rodríguez-Carballeira M; Pessarrodona A; Chabrera C
    Clin Transl Oncol; 2017 Nov; 19(11):1393-1399. PubMed ID: 28808943
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does predicting positive nonsentinel nodes answer the question of axillary dissection and provide a benefit?
    Slomski C; Julian TB
    J Natl Cancer Inst; 2012 Dec; 104(24):1858-9. PubMed ID: 23221924
    [No Abstract]   [Full Text] [Related]  

  • 20. Partial axillary lymph node dissection inferior to the intercostobrachial nerves complements sentinel node biopsy in patients with clinically node-negative breast cancer.
    Li J; Jia S; Zhang W; Qiu F; Zhang Y; Gu X; Xue J
    BMC Surg; 2015 Jun; 15():79. PubMed ID: 26123412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.